1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 19 to 90 Sponsor: Other Protocol IDs: SuMo-Sec-01, PEI 0899/01, IRB 07/03, NCT00108875
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: VicOryx, NCT01462838
|
|
3.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: GOG-0265, NCI-2011-02671, NCT01266460
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 50 Sponsor: Pharmaceutical / Industry Protocol IDs: HPV-003, NCT01304524
|
|
5.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 9100205963, NCT00155766
|
|
6.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: JHOC-J0656, J0656, NA_00002176, NCT00788164
|